01 1Emcure Pharmaceuticals
01 1NEOSTIGMINE METHYLSULFATE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-10-27
Pay. Date : 2014-08-27
DMF Number : 28397
Submission : 2014-07-08
Status : Active
Type : II
20
Emcure Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is NEOSTIGMINE METHYLSULFATE USP, with a corresponding US DMF Number 28397.
Remarkably, this DMF maintains an Active status since its submission on July 08, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 27, 2014, and payment made on August 27, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
